Search Results 1021-1030 of 21658 for Inhibition

1. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   ... inhibitor does not have to necessary be the last line of treatment). ... inhibitors, antiplatelet agents (e.g., clopidogrel) or new oral anticoagulants ...

2. Publications - Janhavi Athale, M.D. - Mayo Clinic

   Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer ...

3. A Clinical Study To Test How Effective And Safe GLPG1690 Is For Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

   Currently taking medication known to be strong inhibitors of CYP3A4. ... Currently taking medication known to be potent inhibitors of P-gp. Acute IPF ...

4. Publications - Aleksandra Kukla, M.D. - Mayo Clinic

   ... Inhibitors in Solid Organ Transplant Consortium. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney ...

5. Mavacamten in Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction Therapy - Mayo Clinic

   ... inhibition of ovulation by oral, implantable, or injectable route of administration;; Intrauterine device;; Intrauterine hormone-releasing system;; Bilateral ...

6. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   Mutant or wild-type Gnaq/Gna11 status. Every effort must be made to avoid administration of drugs that are inhibitors or inducers of cytochrome P450 1A2 (CYP1A2) ...

7. New cholesterol guidelines are more personalized - Mayo Clinic News Network

   ... inhibitor if further cholesterol reduction is needed. Infectious Diseases A-Z: Understanding antibiotic resistance during World Antibiotic Awareness Week.

8. Tumor microenvironment - Department of Cancer Biology - Mayo Clinic Research

   Radisky's research team is working to develop new, more-selective drugs based on the tissue inhibitors of metalloproteinases (TIMPs), natural human proteins ...

9. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   ... inhibitors; participants with melanoma with actionable BRAF mutations (e.g., V600) must have failed or are intolerant to prior treatment with BRAF inhibitors.

10. Joanna M. Biernacka, Ph.D. - Mayo Clinic Faculty Profiles

    ... inhibitors (SSRIs). These studies include data from the Mayo Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomics Study (PGRN-AMPS) ...